AGP Executive Report

Aging Milestone: Japan’s centenarian population hit a record 107,677, with 88% women, as the health ministry points to better living conditions, diet and nutrition, plus medical advances. Sports & Health Logistics: Asian Games organisers in Aichi-Nagoya said they were caught off guard by complaints about cramped container-style athlete housing and promised more comfortable stays for the final week. Medical Tech Showcase: TamaBio will present its synthetic biomembrane platform at the American College of Surgeons Clinical Congress in Washington, aiming to tackle implant issues like adhesion, calcification, infection and fluid leakage. Longevity & Care Focus: A Japanese study reports emergency abdominal surgery can be feasible for patients over 85, adding practical options for older patients in urgent settings. Public Health Nutrition: Diet experts weigh in on sardines—nutrient-rich and convenient—but note they’re not ideal for everyone, depending on individual needs and intake. Healthcare Business Watch: Fortis Healthcare says it is a “complete stranger” to the Daiichi Sankyo–Singh Brothers dispute after the Supreme Court cleared a forensic audit path. Wellness Trend: Japan is tightening rules as regenerative medicine treatments spread, reflecting growing oversight pressure as the field expands.

Sports Medicine & Safety: A WTA player, Tatiana Prozorova, was ruled unfit after a ball hit her face during doubles, triggering concussion protocol and forcing her out of a Singapore Open semifinal—another reminder of how quickly head injuries can sideline athletes. Healthcare Policy Roundup: The HCPFive highlights major FDA moves this week, including priority reviews and insulin approvals, plus label updates for pulmonary arterial hypertension and other conditions—useful for clinicians tracking regulatory momentum. Clinical Research: New studies span dry eye treatment trials (TRPV1-focused approaches), needlestick injury risk among healthcare workers, and multiple oncology-focused nanoparticle and drug-delivery papers, reflecting continued push for faster, targeted therapies. Japan Health & Care Access: Japan’s Defense Ministry plans a startup-friendly contract system for unmanned aerial vehicles, aiming to speed innovation—relevant to future medical logistics and base operations. Public Health & Community: Japan’s centenarian milestone (100,000+) and ongoing aging-related coverage underscore the growing need for prevention, support, and long-term care planning. Injury & Emergency Care: A Gifu man was arrested after allegedly throwing his two daughters from a sixth-floor balcony; both children were conscious and taken to hospital, spotlighting the stakes for rapid emergency response.

Aging & Caregiving: Japan is seeing “grandchild leave” spread as working grandparents help with child care, with companies and local governments offering paid leave to support families amid longer working lives. Local Health Support: Hitachiota, Ibaraki will start paying residents via digital local currency for helping elderly or disabled neighbors take out household waste—aiming to reduce daily burdens for people who struggle with garbage disposal. Public Health Research: A review of millions of people reports COVID-19 is linked with a higher risk of developing new autoimmune diseases afterward, urging clinicians to stay alert to post-acute autoimmune presentations. Animal Health & Climate: Tokyo’s Tama Zoo says three lionesses died during a record heat wave, with necropsies pointing to dehydration and multiple organ failure. Cancer Screening (Japan-linked): A Canadian doctor is sharing training from Japan on adding a quick hypopharynx check during upper endoscopy to catch throat cancers earlier. Drug Development: Daiichi Sankyo and Merck voluntarily withdrew a U.S. accelerated-approval bid for ifinatamab deruxtecan in extensive-stage small cell lung cancer, while a phase 3 trial continues.

FDA Review Watch: The FDA has granted priority review for perioperative durvalumab (Imfinzi) plus enfortumab vedotin (Padcev) in muscle-invasive bladder cancer patients who can’t take cisplatin, based on the VOLGA trial, with an action date targeted for Q4 2026. Cancer Pipeline: The FDA also started a speedy review of Imfinzi in bladder cancer, underscoring how quickly regulators are moving on oncology combinations. Japan Health Research: Oita University will open Japan’s first university research hub focused on the medical, wellness and cosmetic benefits of hot-spring bathing, aiming to support longer healthy life expectancy and local wellness tourism. Clinical Long-Term Data: Legend Biotech released 5-year follow-up results for CARVYKTI in relapsed/refractory multiple myeloma, reporting 50% of patients alive and progression-free after a single infusion. Public Health & Safety: A woman died after becoming unresponsive during a guided wreck dive on USS Emmons off Okinawa; authorities are investigating the circumstances. Community & Aging: Malaysia is debating pension reform to prevent old-age poverty as populations age, highlighting the broader regional pressure on health and welfare systems.

FDA Approves Once-Weekly Insulin for Type 2 Diabetes: Eli Lilly’s Onswik (insulin efsitora alfa-gobe) has been cleared by the US FDA as an add-on to diet and exercise, aiming to improve blood sugar control and cut injections by more than 300 per year versus daily basal insulin. Japan Sports & Health Spotlight: Seventeen-year-old Japan swimmer Shin Ohashi set a new 200m breaststroke world record at the Asian Games in Tokyo, shaving more than half a second off the previous mark. Mental Health in the Military: A Navy psychiatrist described how structured care—sleep support, therapy coordination, and brief medical help—helped a Sailor recover from severe anxiety and insomnia and return to full mission readiness. AI Governance Talks: US and China leaders met for a second summit, with both sides pledging to improve AI governance and keep development “under human control,” while Taiwan and Iran remain key flashpoints. Japan Longevity Milestone: Japan surpassed 100,000 centenarians for the first time, underscoring the scale of the country’s aging challenge. Book Trade Signals New Demand: Japan’s used bookstores are booming as AI firms ship large volumes of books overseas for scanning and shredding, including titles spanning philosophy, history, law, and medicine.

Asian Games Health & Safety: Thailand’s delegation is slamming the Nagoya-hosted 2026 Asian Games as “chaotic,” citing poor accommodation, room shortages, airport delays, and erratic transport that can disrupt athletes’ recovery and routines. Aging & Care Costs: Osaka Metropolitan University research links participation in community gathering places with lower long-term care costs among older adults, including those already needing support—suggesting social participation may be a practical preventive-care lever. Cancer Immunotherapy Update: SL Science presented new preclinical data at the Japanese Cancer Association meeting showing unmodified γδ T cells preferentially kill MGMT-positive glioblastoma cells and outperform conventional αβ approaches in lab models. Hospital/Device Industry: Profusa says GMED has issued a positive decision for ISO 13485 certification progress toward CE marking for its Lumee® Oxygen Platform, a step toward broader EU medical device rollout. Healthcare Business in Japan: Malaysia’s IHH Healthcare says its subsidiary has appealed a Tokyo court dismissal in its Daiichi Sankyo damages dispute tied to Fortis Healthcare—while also planning to raise its Fortis stake to 51% over coming years. Nutrition & Food Tech: Singapore researchers report oyster mushroom fermentation can upgrade okara (soy by-product) by boosting protein and umami flavor while reducing sourness, pointing to higher-value wellness ingredient potential.

Japan Health Policy & Access: Merck says Japan has approved subcutaneous pembrolizumab (Keytruda Qlex/Keyject) for all approved indications, aiming for faster, easier dosing (about 1 minute every 3 weeks or 2 minutes every 6 weeks). Cancer & Oncology Pipeline: Hutchmed will present late-breaking Phase III data on a savolitinib plus osimertinib combo for EGFR-mutated NSCLC at ESMO, including SAFFRON and SANOVO results. Mental Health Treatment Options: A Journal of Clinical Psychiatry study suggests alternative maintenance dosing strategies for paliperidone palmitate (ERZOFRI) in schizophrenia, using simulations to support less frequent dosing flexibility. Dermatology Innovation: Evommune plans to share Phase 2a EVO301 data for moderate-to-severe atopic dermatitis at the EADV Congress, targeting IL-18 upstream inflammation. Women’s Health Screening: Teal Health raises $22M for an at-home HPV cervical cancer screening device, expanding telehealth follow-up and payer/provider partnerships. Global Healthy Living Economics: A UNGA-linked whitepaper estimates eliminating modifiable health risks could unlock $16.4T in annual global GDP by 2050. Mobility & Rehab Tech: Permobil unveils the compact M4 Nexa mid-wheel-drive power wheelchair at REHACARE, with modular seating adjustments. Clinical Safety Watch: Lawsuits in the US allege GLP-1 drugs are linked to sudden vision loss (NAION), despite studies reporting no clear cause-effect.

Underweight trend in South Korea: New data from the Korea Disease Control and Prevention Agency shows 6.2% of women were underweight in 2025 (BMI ≤18.5), nearly four times the rate for men, with Seoul the highest at 8.2%, raising concerns about a “thinness” culture and related health risks. Care tech for long-term facilities: Voxela, backed by Japan’s Delight Ventures and Sompo Growth Partners, says its vision AI can detect incidents in long-term care and draft documentation quickly, aiming to reduce caregiver workload and expand deployments in Japan and the US. Halal market push: Bangladeshi exporters are showcasing food and pharma products at Malaysia’s Mihas, targeting a $3.5T global halal economy and using an AI sourcing system to match buyer needs. Healthy aging policy talk: A UN side event on aging emphasized prevention and early detection, with Japan among the countries contributing perspectives. Japan-linked health research: A new UK-Japan restorative immunology centre will study why inflammation persists in immune-mediated diseases, aiming for therapies that restore immune balance rather than just manage symptoms. Cardiac care collaboration: Kenya’s KNH is running “10 Hearts, One Mission,” bringing international specialists (including from Japan) to perform complex open-heart surgeries and train local teams. Nutrition and wellness culture: Hyderabad’s Matcha Land festival highlights matcha tastings, workshops, and wellness activities, reflecting growing demand for Japanese-style green tea experiences.

Longevity Milestone: Japan has topped 100,000 centenarians for the first time, reaching 107,677 people aged 100+—a new data point that keeps “healthy aging” in the spotlight for both residents and wellness travelers. Cancer Diagnostics: A new blood-based PANXEON liquid biopsy approach combining microRNA signals with CA19-9 shows strong performance for earlier pancreatic cancer detection, with reported high sensitivity for stage I–II disease. Hearing Health: Manga artist Eiji Hashimoto says he has fully lost hearing in his right ear after sudden hearing loss in April, describing treatment and rehabilitation and the day-to-day impact. Drug Manufacturing: Chugai Pharma plans to invest about 100 billion yen per year in facilities and equipment by 2028 to boost in-house output and reduce outsourcing. Obesity Drug Affordability: Coverage highlights how the high cost of obesity drugs is widening health gaps, underscoring access concerns beyond clinical effectiveness. Regional Wellness Spotlight: Wai Ariki Hot Springs and Spa in Japan’s partner region Rotorua wins Oceania and New Zealand “Best Day Spa” at the World Spa Awards, reflecting global demand for wellness experiences. Caregiving in Dementia: A forum piece argues dementia care should blend family involvement with properly trained paid caregivers, focusing on dignity and communication—not just physical help.

A&E Reform in England: England is extending “Martha’s Rule” to every hospital A&E, giving patients, families and staff 24/7 access to an urgent second-opinion review via a dedicated phone number; a pilot saw 69 calls over eight months, with some patients later getting urgent surgery or ICU transfer, and the full rollout is due by March 2028. Women’s Longevity Market: Boston Consulting Group says the global women’s longevity market has an extra $350 billion opportunity, driven by perimenopause/menopause consumers who spend more but feel underserved and would pay more if better products existed. Japan Disaster Health Context: Typhoon Dujuan hit Japan with at least four deaths from landslides and widespread disruption, including major evacuations and power outages—raising urgent needs for medical response and continuity of care. Cancer & Biotech Updates: Adagene’s HER2×CD3 double-masked T-cell engager ADG138 cleared by China’s NMPA for IND, with first-in-human Phase 1 planned for Q4 2026; MediWound received $3.3 million non-dilutive U.S. Department of War funding to develop a room-temperature-stable NexoBrid formulation for battlefield burn care. Sports Medicine Spillover: Real Madrid says Federico Valverde has a grade 3 left ankle sprain, likely sidelining him for weeks and affecting international availability.

Vaccine Security: Japan will consider how to sustain COVID-era vaccine production capacity to be ready for future outbreaks, as health officials weigh domestic resilience after delays tied to overseas development and manufacturing. Cancer Care Update: Japan has approved subcutaneous pembrolizumab for all indications already approved for the drug, and also cleared T-DXd and Dato-DXd in select first-line metastatic breast cancer settings—moves that could broaden treatment options and convenience for patients. Longevity Milestone: Japan surpassed 100,000 centenarians for the first time, underscoring the scale of the aging challenge and the need for long-term health and care systems. Hospital Access Reform: England is expanding “Martha’s Rule” to accident and emergency departments, aiming to make second opinions and urgent clinical reviews easier after a sepsis case tied to delayed escalation. IBD Trend in Asia: Crohn’s disease cases in Korea more than doubled over a decade, with many patients diagnosed in their 20s and 30s—highlighting rising inflammatory bowel disease pressure across the region.

Japan Longevity & Aging Care: Japan has topped 100,000 centenarians for the first time, reaching 107,677 (mostly women), underscoring how fast health and social systems must adapt to extreme old age. Public Health Access & Equity: A Ghanaian man in Japan lost a Supreme Court bid for welfare denied because he is a foreigner, with a dissent arguing the exclusion is unconstitutional for people unable to work during medical treatment. Community Health Infrastructure: Japan’s neighborhood sento bathhouses have fallen by more than 80% in 50 years to 2,730 nationwide, as home bathing spreads, operators age, buildings deteriorate, and fuel costs rise. Clinical Research & Diagnostics (Japan-linked): Craif says it has run more than 110,000 urine-based cancer screenings in Japan and is expanding R&D via a new San Diego lab. Gene Therapy Breakthrough: Beacon Therapeutics reported Phase III success for its gene therapy in XLRP, moving toward potential approval after VISTA met key endpoints. Healthcare Tech Growth Signals: Multiple reports highlight rapid growth in clinical trial management systems, sensor patches, and robotics—pointing to continued investment in remote monitoring and automation.

Menopause Treatment Update: A new explainer breaks down how Veoza (fezolinetant) differs from hormone replacement therapy for menopausal hot flushes and night sweats, focusing on its brain temperature-control pathway rather than replacing hormones. Sleep Medicine in Japan: Viatris says Japan’s health ministry approved WAKIX (pitolisant) for narcolepsy and excessive daytime sleepiness linked to obstructive sleep apnea, positioning it as a first-in-class option in the country for these indications. GLP-1 Safety Watch: Reports highlight mounting lawsuits and claims linking GLP-1 drugs to rare, potentially permanent vision loss, with calls for eye checks when starting treatment. Longevity Milestone: Japan has surpassed 100,000 centenarians, underscoring the scale of the country’s aging challenge and the need for long-term health planning. Disaster Forensics: Nepal’s flood victim identification effort is straining small forensic labs as thousands of relatives await results, with international support including from Singapore. Workforce & Tech: Hawaii leaders discuss how AI and emerging tech are reshaping workforce needs, a theme that resonates for healthcare staffing and training.

Japan-Philippines Diplomacy: Japan’s ambassador-designate Katsuro Kitagawa pledged to deepen people-to-people ties as Manila and Tokyo elevate relations to a comprehensive strategic partnership. Sports Medicine & Safety: At the Nagoya Asian Games, India’s MMA fighter Varun Sanyal withdrew after cramps and body aches following a sauna during a weight cut; officials said tests were normal but he still felt unfit. Team Support & Recovery: Kyrgyzstan’s Asian Games delegation includes doctors and masseurs for athlete medical care and recovery, underscoring the growing focus on on-site health support. Wellness & Lifestyle: A new report highlights a “packed lunch revival” driven by higher food costs and a shift toward more nutritious lunch bowls, reflecting how everyday nutrition habits are changing. Health Tech in Japan: GMO unveiled a “Humanoid Ambulance” to troubleshoot humanoid robots on-site, signaling how healthcare-adjacent robotics services are expanding beyond hospitals. Public Health Context: Hong Kong Customs seized about 13kg of suspected ketamine from a Japanese passenger, reminding travelers that drug trafficking carries severe penalties.

Longevity Milestone: Japan’s Health and Welfare Ministry says the number of centenarians has topped 100,000 for the first time, reaching 107,677 (about 88% women), highlighting both medical progress and the pressure on a sustainable social security system. Wellness & Exercise Research: A University of Tsukuba study suggests very slow running for just 10 minutes can boost prefrontal brain activity and improve mood and executive function, offering a low-intensity option for people who struggle with harder workouts. Dry Eye Care: New clinical research compares evidence-based guidelines with real-world enteral nutrition practices in intensive care, while another study looks at short-term changes in ocular discomfort after an add-on treatment for dry eye patients—both pointing to ongoing efforts to refine symptom-focused care. Healthcare Innovation Watch: Lilly shared early clinical promise for brenipatide, a once-weekly GIP/GLP-1 candidate aimed at substance use, psychiatric and immunologic disorders, with Phase III plans for major depressive disorder and alcohol use disorder. Policy & Workforce: Japan’s Defense Ministry is considering a new agency to help retiring Self-Defense Forces members and their families transition into civilian jobs, aiming to ease recruitment challenges amid an aging society.

Dengue Alert in Japan’s Region: Tamil Nadu is seeing a dengue surge with monsoon rains. Health officials report 244 confirmed cases out of 1,320 tested and nearly 200 new cases daily; Chennai is among the hardest hit, with 87 dengue-positive patients among 156 fever admissions in one day. Authorities have deployed 25,000 workers for mosquito control, sanitation, and fever monitoring, urging residents to prevent water stagnation and seek care for persistent fever. Medication Safety & Adherence: A new cross-sectional study on adult liver transplant recipients highlights the role of medication literacy and social support in adherence, underscoring how complex lifelong immunosuppressant regimens can drive missed doses and higher rejection risk. Japan’s Aging Milestone: Japan’s centenarian population has topped 100,000 for the first time, reflecting rapid population aging and raising long-term pressure on welfare and healthcare systems. Cancer Care Update (Japan): Japan has approved a T-DXd combination and Dato-DXd for first-line metastatic breast cancer, signaling continued expansion of treatment options for patients. Sports Medicine Angle: As the Asian Games begin in Aichi-Nagoya, athletes and teams are already in action—an indirect reminder of the importance of prevention, recovery, and safe medication use in high-performance settings.